Company intelligence / Profile preview

Deutsche Pharma

Santiago, Región Metropolitana, Chile

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Deutsche Pharma is a Chilean pharmaceutical company dedicated to the development, manufacturing, and commercialization of a wide range of therapeutic products. The company focuses on providing high-quality affordable medicines across various therapeutic areas, including pain management, respiratory health, and infectious diseases. With a strong presence in the Latin American market, Deutsche Pharma operates modern manufacturing facilities that comply with international quality standards. Their business model encompasses both the production of proprietary branded generics and the distribution of specialized healthcare products.

Therapeutic areas: ImmunologyNeurologyDermatologyInfectious DiseasesPulmonologyGastroenterology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Deutsche Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deutsche Pharma.

Explore the full profile